S-1/A: Buda Juice IPO: UltraFresh Pioneer Seeks NYSE Listing

Buda Juice, Inc. files for an initial public offering to raise up to $20 million, aiming to list on the NYSE and fund its national expansion of UltraFresh™ cold-crafted juice production.

Summary

• Buda Juice, Inc. is undertaking an Initial Public Offering (IPO) of 2,666,667 shares of common stock, with 2,000,000 shares offered by the Company and 666,667 shares by CEO Horatio Lonsdale-Hands (Selling Stockholder).
• The estimated IPO price range is between $7.50 and $9.00 per share, with $7.50 assumed for certain financial data.
• The Company expects to receive approximately $13,788,176 in net proceeds from its share sale (assuming a $7.50 IPO price and no over-allotment), with no proceeds from the Selling Stockholder's sale.
• Proceeds will be used to lease, develop, and furnish two new production plants in South Carolina (projected 2026) and Arizona/Nevada (projected 2027), expand the existing Dallas plant, and for general corporate purposes, including working capital.
• Buda Juice, LLC is converting to Buda Juice, Inc., a Delaware corporation, immediately prior to the IPO closing.
• The company is classified as an 'emerging growth company' and 'smaller reporting company,' which allows for reduced public company reporting requirements.
• An application has been made to list the Common Stock on the New York Stock Exchange (NYSE) under the symbol 'BUDA', with the closing of the Offering contingent upon successful listing.
• Revenue grew from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.8% Compound Annual Growth Rate (CAGR).
• Net sales increased 17.0% to $6,547 thousand for the six months ended June 30, 2025, from $5,598 thousand for the same period in 2024.
• Net income increased 16.1% to $1,977 thousand for the six months ended June 30, 2025, from $1,702 thousand for the same period in 2024.
• Gross margin for the six months ended June 30, 2025, was 45.9%, a decrease from 48.7% for the same period in 2024, primarily due to increased cost of goods sold volume.
• One customer accounted for approximately 97% of net sales for the six months ended June 30, 2025 (compared to 95% in 2024 and 90% in 2023), indicating high customer concentration.

Sentiment

Score: 7

Explanation: The company exhibits strong historical financial growth and profitability, a compelling differentiated product in the 'UltraFresh™' category, and a clear, disciplined geographic expansion plan. The IPO aims to fund this growth, which is a positive. However, the extremely high customer concentration (97% from one customer) presents a substantial and immediate risk. The inherent challenges of managing short shelf-life products in a competitive market, along with significant dilution for new investors, temper the overall sentiment. The company's ability to diversify its customer base and execute its expansion strategy will be critical.

Positives

• Demonstrated strong revenue growth with a 41.8% CAGR from $5.6 million in 2022 to $11.2 million in 2024.
• Maintained consistent profitability, reporting net income of $3.574 million in 2024 and $1.977 million for the first six months of 2025.
• Pioneering the 'UltraFresh™' juice category with a unique end-to-end cold chain platform, differentiating from competitors using heat-treatment or HPP.
• Executing a disciplined geographic expansion strategy with planned new production facilities in South Carolina (2026) and Arizona/Nevada (2027) to serve a large percentage of the U.S. population.
• Leverages an asset-light model and established long-term relationships with citrus growers, providing competitive advantages in supply chain and cost efficiency.
• The executive team brings decades of experience and established relationships with major U.S. grocery retailers, facilitating market entry and expansion.
• Initiated customer diversification efforts, including new sales with a national retailer, aiming to mitigate concentration risk.

Negatives

• High customer concentration, with one customer accounting for 97% of net sales for the six months ended June 30, 2025, posing a significant risk if this relationship deteriorates.
• Limited operating history in new and evolving markets, making it difficult to evaluate future prospects and plan for growth outside current regions.
• Reliance on a limited number of cold chain-dependent production and distribution facilities, making operations vulnerable to mechanical failure, labor shortages, or natural disasters.
• The business model's dependence on maintaining strict cold chain logistics adds operational complexity, higher costs, and vulnerability to temperature excursions or logistical delays.
• Dependence on a limited number of suppliers for raw materials, creating potential risks of supply disruption or price increases.
• Short shelf-life products increase exposure to inventory spoilage, write-downs, and stockouts, requiring precise demand forecasting and logistics.
• New investors purchasing Common Stock in the offering will experience immediate and substantial dilution of $6.25 per share (assuming a $7.50 IPO price).
• The management team has limited experience operating a public company, which will incur increased costs and may divert attention from day-to-day business management.
• The company does not intend to pay dividends on its Common Stock in the foreseeable future, meaning returns depend solely on stock price appreciation.

Risks

• Limited operating history in new and evolving markets may make it difficult to evaluate current business and future prospects.
• Historical financial and operating results may not be indicative of future performance, and the company may not sustain historical profitability levels.
• Operates in a highly competitive beverage industry against larger and better-capitalized competitors.
• Success depends on the continued strength of the brand and consumer perception of product quality, safety, freshness, and healthfulness.
• Future growth depends on the successful development and acceptance of new products and product innovation.
• Reliance on a limited number of cold chain-dependent production and distribution facilities; any disruption could materially affect operations.
• Business model depends on maintaining strict cold chain logistics from sourcing through delivery, adding operational complexity, cost, and vulnerability.
• Dependence on the availability, cost, and quality of fresh citrus and other raw ingredients; agricultural or climate-related disruptions could adversely affect supply and margins.
• Production facilities must maintain compliance with rigorous food safety and regulatory standards; any lapse or contamination could result in product recalls, liability, or reputational harm.
• Risks associated with managing short shelf-life products, increasing exposure to inventory spoilage, write-downs, and stockouts.
• Changes in consumer preferences, particularly away from fresh juice, citrus beverages, or premium-priced fresh products, could adversely affect demand.
• Growth strategy depends on geographic expansion, which requires securing and equipping new facilities and may be costly and complex.
• One customer accounts for 97% of net sales for the six months ended June 30, 2025; loss of this customer would have a material adverse impact.
• Dependence on a limited number of suppliers for products; loss of one or more could disrupt operations or increase costs.
• Growth depends on expanding distribution through new retail relationships and deeper penetration with existing accounts; failure to secure or maintain these relationships may limit revenue potential.
• Heavy dependence on third-party retailers and brokers to market and sell products; their shelf prioritization, execution, or financial health may directly impact performance.
• High-tech driven, centralized production systems are core to efficiency and quality; technical failures or cybersecurity incidents could disrupt operations or result in data loss.
• Reliance on third-party logistics providers for delivery; any breakdown or delay could damage product integrity and customer trust.
• Difficulties in forecasting demand accurately could lead to excess inventory, underproduction, missed revenue opportunities, or higher working capital needs.
• Failure to effectively manage growth, including geographic expansion and increased retail distribution, could cause operations and customer experience to suffer.
• May be subject to legal challenges related to the accuracy of health and wellness claims.
• Future success depends on the ability to attract, retain, and develop key employees and senior leadership.
• May require additional capital to support growth strategy or operations, and such financing may not be available on acceptable terms or at all.
• Disruptions in the worldwide economy may adversely affect business, financial condition, results of operations, and cash flows.
• Climate change, or legal or market measures to address climate change, may negatively affect business and operations.
• Fluctuations in business conditions may unexpectedly impact reported results of operations and financial condition.
• Insurance may not provide adequate levels of coverage against claims or otherwise protect from all risks.
• Members of the management team have limited experience in operating a public company, and regulatory compliance may divert their attention.
• Will incur increased costs as a result of operating as a public company.
• Food safety and food-borne illness incidents or other safety concerns may materially adversely affect business.
• Failure to comply with federal and state laws and regulations relating to data privacy, data protection, advertising, and consumer protection could adversely affect business.
• Litigation or legal proceedings could expose to significant liabilities and have a negative impact on reputation or business.
• Legislative or regulatory changes that affect products, including new taxes, could reduce demand or increase costs.
• Failure to comply with requirements to design, implement, and maintain effective internal controls could have a material adverse effect on business and stock price.
• Reliance heavily on information technology systems; any significant failure, inadequacy, interruption, or data security incident could adversely affect business.
• May be unable to adequately protect intellectual property or may face claims of infringement from others.
• No prior public market for Common Stock; an active market may not develop or be sustainable.
• The price of Common Stock may be volatile, and purchasers could incur substantial losses.
• A portion of the shares offered will be sold by the Selling Stockholder (CEO).
• A substantial portion of total issued and outstanding shares may be sold into the market at any time, potentially causing the market price to drop.
• If the NYSE listing application for Common Stock is not approved, the Offering will be terminated.
• Authorized to issue blank check preferred stock without stockholder approval, which could adversely impact the rights of Common Stock holders.
• As an emerging growth company, not required to comply with certain reporting requirements applicable to other public companies.
• Broad discretion in the use of net proceeds from the Common Stock sold in the offering.
• No intention to pay dividends on Common Stock.
• No independent valuation of stock, meaning Common Stock may be worth less than the offering price.
• If securities industry analysts do not publish research reports or publish unfavorable reports, the market price and trading volume could be negatively affected.
• Delaware law and provisions in the certificate of incorporation and bylaws could make a merger, tender offer, or proxy contest more difficult.
• Reliance on Section 8(a) of the Securities Act could result in adverse consequences, including the need for post-effective amendments or a stop order.

Future Outlook

The company plans disciplined geographic expansion through a three-facility hub model, with new production facilities projected for South Carolina in 2026 and Arizona/Nevada in 2027, alongside expansion of its existing Dallas plant. This strategy aims to serve a large percentage of the U.S. population and significantly expand revenue by diversifying across retail, food service, and direct-to-consumer channels. The U.S. fruit juice market is projected to grow from $55.5 billion in 2024 to $77.5 billion by 2033 (3.8% CAGR), and the global lemonade segment is expected to reach $16.7 billion by 2034 (6.3% CAGR), indicating a favorable market environment for the company's growth initiatives.

Management Comments

• "At Buda Juice, we started small—one RAW.ORGANIC.REAL. sip at a time." Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer.
• "We are pioneering a new category in beverages, UltraFresh™ juice, offering cold-crafted citrus-based drinks that are never heat-treated, never HPP-processed and always cold." Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer.
• "We believe our opportunity is brilliant. We are not simply capturing market share—we believe we are expanding the refrigerated juice category itself by helping retailers evolve to the next generation of freshness." Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer.
• "Our vision is to make UltraFresh™ juice the new standard, providing clean beverages in every grocery store across the U.S., without compromise on safety, taste or nutrients." Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer.
• "While many companies at our stage and with our growth profile adopt a growth-at-all-cost mindset, we have always been focused on production safety first, profitable, responsible, and sustainable growth." Management Discussion and Analysis.

Industry Context

Buda Juice is strategically positioning itself in the 'UltraFresh™' juice category, aiming to differentiate from both traditional heat-processed (e.g., Tropicana, Minute Maid) and High-Pressure Processed (HPP) products (e.g., Suja Juice, Naked). The company's continuous 35F cold chain platform addresses the operational complexities that limit most grocery retailers from offering in-store freshly squeezed juice, an underserved market segment. This approach aligns with growing consumer demand, particularly among Generation Z and Millennials, for natural, healthy, convenient, and fresh beverage options. By solving the challenge of delivering fresh-crafted quality at retail scale, Buda Juice seeks to expand the refrigerated juice category itself, rather than merely competing for existing market share within the broader U.S. fruit juice market, which is valued at $55.5 billion in 2024 and projected to grow.

Comparison to Industry Standards

• Buda Juice's 'UltraFresh™' process, which involves cold-crafted citrus-based drinks that are never heat-treated, HPP-processed, or UV-treated and always cold, directly contrasts with the dominant heat-pasteurization methods used by major players like Tropicana (PepsiCo) and Minute Maid/Simply Orange (Coca-Cola), which extend shelf life (60 days to 12 months) but degrade flavor and heat-sensitive nutrients.
• The company differentiates from HPP technology, utilized by competitors such as Suja Juice, Naked, Evolution Fresh, and Bolthouse Farms, which extends shelf life to 30-90 days and preserves more nutrients than heat processing, but Buda Juice claims it still alters molecular structure and does not achieve 'true fresh taste.'
• Unlike boutique cold-pressed juice bars that offer products with a 3-5 day shelf life but face challenges with inconsistent quality, high production costs, and limited distribution, Buda Juice's centralized production model aims for consistent quality and an 8-12 day shelf life suitable for retail distribution.
• Buda Juice's model provides a 'turnkey solution' for grocery retailers, eliminating their need for dedicated clean spaces, specialized equipment, trained labor, and food safety management required for traditional in-store fresh-squeezed juicing (a capability present in less than 5% of U.S. grocery stores), thereby offering a competitive advantage in operational simplicity and cost for retailers.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not currently a party to any material legal proceedings.
• Approximately six years ago, the company faced a third-party opposition from a kombucha company using the name 'Buddha' during its trademark application process in Canada, which was abandoned as Canadian registration was not deemed necessary for the U.S. market.
• On June 28, 2024, the company identified a misappropriation of assets totaling $103 by a former employee, which was fully recovered through an insurance claim and bank charge reversals.

Related Party Transactions

• The revolving line of credit with Amegy Bank, which had a $3,000,000 borrowing capacity and was extended to July 8, 2026, is supported by personal guarantees from three members of the Board of Directors: Horatio Lonsdale-Hands (CEO), Bryan Herr (Executive Chairman), and Bernard Lucien Nussbaumer (Co-Founder, Director).
• Karina Farquharson, the Vice President of Marketing & Data Analytics, is the wife of the CEO, Horatio Lonsdale-Hands.

Stakeholder Impact

• Shareholders: Potential for capital appreciation through IPO and future growth, but face immediate and substantial dilution. No dividends are planned in the foreseeable future. High customer concentration poses a significant risk to investment.
• Employees: Benefit from the adoption of a new equity incentive plan (15% option pool) designed to attract, motivate, and retain talent, aligning their interests with long-term company success. New CFO appointment.
• Customers (Retailers): Offered a 'turnkey solution' for fresh juice, eliminating operational complexities and infrastructure investments, potentially leading to increased store traffic and sales for them. However, the high concentration with one major customer creates dependency.
• Suppliers: Long-term relationships with citrus growers are crucial for consistent premium fruit supply, but reliance on a limited number of suppliers introduces supply chain risk.
• Creditors: The company has repaid its line of credit and has no outstanding debt as of June 30, 2025, and the facility is personally guaranteed by board members, indicating a strong credit position.

Next Steps

• Consummate the statutory conversion from Buda Juice, LLC to Buda Juice, Inc. immediately before the IPO closing.
• Complete the IPO and list Common Stock on the NYSE under the symbol BUDA, contingent on NYSE approval.
• Lease, develop, and furnish a new production plant in South Carolina, projected to be completed in 2026, to serve the Southeast and Mid-Atlantic regions.
• Lease, develop, and furnish a new production facility in Arizona/Nevada, projected to be completed in 2027, to serve the Western U.S. markets.
• Expand the existing Dallas plant and invest in continuing capital expenditure initiatives.
• Implement a multi-channel sales approach, including regional and national broker networks, and leverage leadership's industry relationships for direct retail access.
• Expand in-store demonstration programs and allocate marketing resources to key markets to accelerate adoption and awareness.
• Develop and support marketing programs to capture growth in the online grocery channel.
• Increase branded product distribution alongside successful private label offerings.
• Develop dedicated sales resources to pursue opportunities in complementary channels such as restaurants, bars, hotels, and institutional food service.
• Adopt the 2025 Incentive Award Plan upon NYSE listing, subject to stockholder approval, to provide equity-based and cash-based awards to eligible personnel.
• Enter into separate indemnification agreements with each director and executive officer.
• Purchase directors and officers liability insurance.
• Adopt a written related person transaction policy to govern future dealings.
• Adopt a clawback policy compliant with Rule 10D-1 under the Exchange Act and NYSE listing standards.

Key Dates

Recommendation

While Buda Juice exhibits strong historical financial growth and profitability, a compelling differentiated product in the 'UltraFresh™' category, and a clear, disciplined geographic expansion plan, the extremely high customer concentration (97% from one customer) presents a substantial and immediate risk. The IPO proceeds will fund growth, but new investors face significant dilution. A 'hold' recommendation is appropriate to allow time to observe the company's progress in diversifying its customer base and successfully executing its ambitious expansion strategy post-IPO before considering a stronger position. The long-term potential is evident, but the concentration risk warrants caution.

Keywords

UltraFresh juice, cold-crafted beverages, SEC filing, IPO, Buda Juice, beverage industry, food and beverage, cold chain logistics, consumer goods, juice market, Delaware corporation, NYSE listing, S-1/A, financial performance, geographic expansion, risk factors, corporate governance, food safety, private label, wellness shots, citrus juice, emerging growth company, financial reporting